Women's health marketing is broken. Here's how strategists can help fix it

Women's health is under-researched, over-marketed and badly segmented, and strategists working in women's health marketing are closer to fixing that than they think. That was the thread running through our most recent Salmon Crew panel.

I was joined by Crew members Anna Harris (B2B strategy lead and school safeguarding governor), Elisabeth Bromberg (brand and social strategist, founder of Mildred Mae), Erica Martinez (strategy lead at a New York healthcare communications agency) and Ally Waring (CX and loyalty consultant, plus a nearly qualified sex therapist).

Here are my notes from our conversation. To get the full recording and tons of other benefits, become a member.

1/ The women's health research gap, in numbers

Key points

  • Men are the default; women are the exception. Look for a figure on men's health research spend and you won't find one, and this is largely because health research is men's health research by default.

  • The funding numbers are stark. According to MM+M, only 8 to 10% of the US National Institutes of Health (NIH) funding goes to women's health research. Women are roughly half the population. So the maths ain't mathin' very well on this one.

  • The wider data backs this up. The McKinsey Health Institute (2024) puts women's health at about 4% of US healthcare R&D, and the NIH's women's-health-specific budget at about 11%. To add a bit more (gloomy) colour, since 1980, medicines have been 3.5 times more likely to be withdrawn for safety risks in women than in men.

  • Closing the gap is a $1 trillion opportunity. McKinsey estimates it could add at least $1 trillion a year to the global economy by 2040. That's roughly $3 of value for every $1 invested. The logic: fewer years lost to poor health means more women able to work, and work more productively. That's the equivalent of 137 million women gaining full-time jobs by 2040. If businesses won't do it for moral reasons, follow the money reasons.

  • Pregnancy is a data desert. Just 11% of drugs approved between 2010 and 2019 included human pregnancy data. The panel's read: this is why women don't trust the healthcare system, and why they're turning to communities instead.

  • "Empowerment" without listening. Health brands and wellness marketing tell women to "take charge of their health", while the research and funding behind the products still leave them out. The empowerment is in messaging, not in the science.

  • Funding is the 2027 battle. The constant fight for research funding for women's products came up as the number one challenge in pharma.

What we as strategists can do

  • Interrogate every data set before you build on it: who was in the sample, when were they counted, and who is missing?

  • Make the gaps visible in the strategic landscape you hand clients. It's an ethical responsibility, not a nice-to-have.

  • Treat "we don't have data on women" as a finding in its own right, and as a commercial opportunity for the client willing to fill it.

2/ How the wellness industry profits from the research gap

Key points

  • Wellness has rushed into the space research left empty. The message to women is "don't worry, we're focusing on you", but then it's delivered by selling them stuff.

  • Private equity has found perimenopause. Social feeds are flooded with psychedelics, ketamine, weight-loss and menopause products nobody asked for, driven by PE and VC money chasing women's growing disposable income post-COVID.

  • Exaggerating difference is a business model. Wellness exploits biological essentialism, inflating the differences between men and women for commercial gain. This risks nudging culture towards tradwife and manosphere territory.

  • Benevolent sexism, monetised. Wellness sells the idea that women need looking after. That's still sexism. The pyramid of violence shows why it matters: everyday stereotypes sit at the base and hold up everything worse above them.

  • The pink tax is real and measurable. One former baby products buyer saw 30% more sales of a single product simply by offering a pink version.

  • "Shrink it and pink it." The industry phrase for products superficially adapted for women. Sometimes literally pink, sometimes just "softer".

What we as strategists can do

  • Ask one question of every brief: how is somebody making money out of this?

  • Add a "who profits" slide to your landscape section. For each player, including the client, note what they sell, who funds them and what they gain if women feel the problem is theirs to fix.

  • Before signing off a "for women" product or range, ask the client two questions. What has changed apart from the colour, size or price? Is there evidence women need that change? If the answers are "nothing" and "no", recommend selling the original to women instead.

  • Back real health products, not pseudo-wellness. The test: was it tested on women, does it make an approved health claim, and does it treat a named condition rather than a vague "glow"?

3/ Why healthcare marketing treats women as one segment

Key points

  • Healthcare flattens women into one group. Consumer strategy at least segments by role (mum, student, daughter). In healthcare, women are mostly "just women".

  • Pharma barely segments at all. On many pharma brands, the only split is "already on the drug" vs "new to the drug". The cynical read: margins are so high there's little incentive to do better.

  • Culture changes the message. Perceptions of weight differ by community. Talking weight loss to white menopausal women is not the same as talking to communities where being heavier is more accepted. GLP-1 ads are improving on representation, but not on cultural nuance.

  • Where it works, it's because biology forced it. In dermatology, conditions like eczema look different on darker skin, so "skin of colour" segmentation exists. See Lilly using spokeswomen of colour for its eczema treatment Ebglyss.

  • Family structures are more complex than briefs assume. Multigenerational households and grandparents raising kids mean you have to dig into who actually makes health decisions.

  • Targeting data isn't as smart as we pretend. With this much data about women, a generic message looks like a missed opportunity. But that assumes the data is right, and ad-targeting often gets even binary gender wrong.

What we as strategists can do

4/ BMI, body image and the algorithms that amplify harm

Key points

  • A woman's body is marketed as a problem to solve. Women's bodies are a "judgement zone" in marketing, while being left out of the research and treatment.

  • BMI was built without women. The metric traces back to a study of around 7,400 men. It still drives health classifications and minimum thresholds for treatments like GLP-1s.

  • Flawed metrics have real consequences. One story from the panel: a "normal" BMI led clinicians to skip malnutrition tests on a seriously unwell patient. The connection was eventually made by a female doctor.

  • Opt-outs don't work. You can switch off weight loss, fitness and nutrition ads on Meta and still be flooded with GLP-1 ads.

  • Algorithms amplify harm, and scale with illness. An audit of around one million TikTok videos found users with eating disorders received 4,343% (yes, you read that right) more pro-anorexia content than a control group in a single month. Researchers checked: the gap was far larger than the users' own engagement could explain.

  • Celebrity body commentary drives risky searches. Media reaction to a woman's body size (such as coverage of Ariana Grande) correlates with rises in anorexia-related searches.

What we as strategists can do

  • Never take BMI, or any body metric, at face value in a brief. Ask where it came from and who it was built on.

  • Design for the most vulnerable person who will see the work, such as a woman or teenage girl with an eating disorder, not the average target.

  • Audit targeting and exclusions on weight, wellness and GLP-1 work. If someone has opted out, the client shouldn't be reaching them.

  • Treat algorithmic amplification as a brand safety risk and put it in the plan.

5/ Sexual health marketing, shame and censorship

Key points

  • Bans without education breed shame. On the UK's new ban on porn depicting strangulation, incest roleplay and adults roleplaying as minors: content showing actual abuse was already illegal, and banning without space for discussion or prevention pushes the problem underground. In sex therapy, sexual dysfunction often starts with feeling something is fundamentally wrong with you. For the full argument around this, read Ally's Porn isn't the problem. It covers the vague "reasonable person" test, gaps in policing and sex education, and why prevention needs funding and open education.

  • Salacious coverage only benefits media and advertisers. When teenagers asked teachers how to choke a girlfriend "safely", the press ran shock headlines. The point: those kids had seen it in porn and had no safe adult to ask.

  • Name things properly. A better approach: acknowledge the question without judgement, use the right term (erotic asphyxiation), check understanding of consent, and refer to a registered sex therapist.

  • Sex Education got it right. In the panel's view (opinion, not research), the show deserves credit for dramatising what happens without proper sex education, and for including people who don't want sex in the first place.

  • Sexual health marketing assumes a couple. Lubricant brand KY's long-standing focus on established couples, in hindsight, excluded single users. Compare Cindy Gallop's openness about single life.

  • Women's sexual health is sold for a man's benefit. Menopause creams and hormone replacement therapy (HRT) ads are "always about you doing it for your man", not your own satisfaction. And nobody talks about sex after 50.

  • What doing it well looks like. Relate's Let's Talk: The Joy of Later Life Sex, made with Ogilvy UK and photographer Rankin, shows older couples of different bodies and sexualities in intimate moments, in their own words. It challenges the idea that older people don't want sex, and gets people talking openly about intimacy as they age. The joy is theirs, not a fix to keep someone else happy.

  • Now it's happening to men too. Voy's (UK) "it's not him, it's his hormones" ads borrow the language once used on women. One theory: they're really targeting women to start the conversation with their partner.

What we as strategists can do

  • Use direct, accurate language on sexual health briefs. Fluffy euphemism protects nobody.

  • Write for single people, older people and non-traditional relationships, not just the established couple.

  • Check whether a sexual health message centres the woman's own satisfaction or her partner's.

  • Bring lived experience into briefs where shame is likely, and name it early.

6/ Menopause marketing, ageing and health span

Key points

  • Perimenopause isn't a life stage. It's several. It can start anywhere from 35 to 55 and lasts different lengths for different women. Menopause itself is the point 12 months after your last period. In short: experience trumps duration, moment and role.

  • It isn't only cis women. Trans men, women who've had their ovaries removed and people treated for certain cancers all go through a form of menopause.

  • Women live longer but less well. For all the "longevity maxing" hype, women outlive men, but with poorer health span (higher rates of bone loss, such as osteoporosis, and dementia), and the systems to support later life haven't caught up.

  • Women spend 25% more time in ill health than men. McKinsey Health Institute: that's an average of nine years of a woman's life spent in poor health.

  • HRT advice keeps shifting. Women once told HRT was off-limits (e.g. because of migraine and stroke risk) are now told it fixes everything. Some remain wary of the science, and of the timing alongside a cultural turn towards tradwife values.

  • Ageing is sold as an appearance problem. In 2025, 94% of cosmetic surgical procedures were on women. Facial fat grafting rose 39% in 2025. 82% of plastic surgeons got GLP-1-related consultation requests. Fillers carry risks of blindness, stroke and tissue death.

  • The 55+ audience is invisible. When brands do address it, it's usually as "about to retire", which is increasingly untrue.

What we as strategists can do

  • Segment perimenopause by symptoms and experience, not by age band.

  • Write menopause briefs that include trans men and surgical or medical menopause.

  • Shift the ageing conversation from looking younger to living well: bone health, cognition, support services.

  • On cosmetic and anti-ageing briefs (fillers, fat grafting, "Ozempic face" fixes), put the medical risks in the strategy, not just the sales opportunity. If the work makes a risky procedure feel routine, say so. Otherwise more women book treatments like fillers without weighing risks such as blindness, stroke or tissue death, and the brand owns the fallout when it goes wrong.

7/ Why "busy mum" isn't a consumer insight

Key points

  • The real insight is in the why. Ask: where does the busyness come from, what pressures drive it, how does it feel, and how does it show up?

  • Busy and cognitively overloaded aren't the same thing. Someone can look idle while carrying the mental load of every household decision, including whether the bins went out.

  • Multitasking is a myth. Research shows women aren't better at multitasking. They just do more. And, as someone added, complain less. Compare that with plenty of men, who do one or two things around the house and quietly feel like they've won the day. I still fall into that trap too. I'm just getting a bit better at catching myself.

What we as strategists can do

  • Bounce any brief that leads with "she's busy". Ask what the load is, where it comes from and what it costs her.

  • No time for research? Talk to three real women. The B2B rule of customer voice first works here too. Start close to home: friends of friends, neighbours, parents at the school gate, colleagues' partners or family. Ask your network for one intro each, and pick people who don't work in marketing.

  • Write for mental load, not time scarcity. Products that remove decisions beat products that save minutes.

  • Drop "great at multitasking" from personas. It flatters and it's untrue.

8/ Gender bias in strategy and the global picture

Key points

  • The sole woman isn't a spokesperson. If there's one female strategist on a women's health account, ask for her view as a strategist, not as a stand-in for all women.

  • Backhanded compliments are bias too. A consultant once told a panellist that clients trusted her because she was "grey enough". The panel's verdict: a compliment with a poison pill, rooted in age and gender expectations.

  • Appearance shapes perception at work. Long, curly or undyed hair can get a woman labelled a hippie or even a witch, stories that follow women into meetings. Even the daily debate about dyeing grey hair came up.

  • Women's rights are historically recent. US women only won the legal right to credit regardless of sex or marital status with the Equal Credit Opportunity Act of 1974.

  • Health needs differ by place. In Mexico, Always' Intimate Words found that Zapotec-speaking women had no words for parts of their reproductive system, so they couldn't describe cervical cancer symptoms. The campaign created those words with the community, and won a Cannes Grand Prix in 2015. A Global North lens doesn't travel.

What we as strategists can do

  • Staff women's health work with diverse teams, and value women's strategic judgement over their demographic.

  • Call out age- and appearance-coded language in the room and in the work.

  • Check whether a brief imports Western assumptions into markets where the basic needs are different. Sometimes the job is giving people the words.

A checklist for women's health marketing briefs

  1. Who's in the data? Interrogate the sample and the language. Are these the words patients actually use?

  2. Who's making money, and how? Lay the commercial agenda out on the table.

  3. Which women, exactly? Account for culture, family structure, life stage and gender identity rather than one flat "women" segment.

  4. Does this reduce shame or add to it? The test: shame is a signal that something has gone wrong, not a sensitive topic to tiptoe round.

  5. Who's the most vulnerable person who will see this? Design for her.

  6. Are we asking the woman on the team for her strategy or her gender?

  7. Is the insight deeper than "she's busy"? Name the load, where it comes from and what it costs her.

  8. Who is this really for, her or her partner? Check that the benefit is hers.

  9. What's actually different for women? If it's only the colour, size or price, it's shrink it and pink it.

Frequently Asked Questions

What is the women's health gap?

It's the shortfall in research, funding and care for conditions that affect women. Women spend about 25% more of their lives in poor health than men, yet only around 4% of US healthcare R&D goes to women's health.

Why does women's health marketing matter for strategists?

Because the research gap has been filled by wellness brands selling fixes. Strategists decide who gets targeted, what gets claimed and which insights make the brief, so they can either repeat the gap or help close it.

When does perimenopause start?

It can start anywhere from 35 to 55 and lasts different lengths for different women. That's why age bands make a poor segment for menopause marketing.

Why is BMI a flawed measure for women?

BMI traces back to a study of around 7,400 men. It still sets health classifications and treatment thresholds, including for GLP-1s, even though women weren't in the original research.

How can I get better insight than "busy mum" on a tight deadline?

Talk to three real women from your own network, such as friends of friends, neighbours or colleagues' family. Ask where the load comes from and what it costs them, not just how busy they are.

References

Next
Next

10 financial services marketing case studies with ROI data